New Delhi, April 8 Zydus Lifesciences Ltd announced on Wednesday that it has received final approval from the US health regulator for its generic version of dapagliflozin tablets, indicated for controlling blood sugar in adults with type 2 diabetes mellitus.The approval from the US Food and...
New Delhi, April 8 Biocon Ltd announced on Wednesday that its subsidiary, Biocon Pharma Ltd, has received approval from the US health regulator for its genetically engineered version of dapagliflozin tablets, indicated for reducing blood sugar levels in adults with type 2 diabetes mellitus.The...